Four publications this week:
- Economic evaluations of next-generation sequencing for targeted therapy in non-small cell lung cancer: a systematic review | link
- PHOENIX: a study protocol for a pilot randomised controlled trial of pre-emptive pharmacogenomic panel testing in acute care settings with health economic evaluations | link
- Cost-Effectiveness of Targeted Next-Generation Sequencing for Diagnosing Pre-XDR and XDR Tuberculosis in Rifampicin-Resistant Patients Across High-Burden Settings | link
- Perspectives in the value assessment of comprehensive genomic profiling: A multi-criteria decision analysis in NSCLC among stakeholders | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.
